View in EDS HTML Full Text PDF Full Text

Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice.

Saved in:
Bibliographic Details
Title: Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice.
Authors: Potrony M; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain., Morales-Romero B; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain., Moreno L; Gastroenterology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Pastor B; Gastroenterology Department, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Grau E; Gastroenterology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Badenas C; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain., Villanueva-Cañas JL; Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain., Montalbán-Casafont A; Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain., Arnau-Collell C; Gastroenterology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Ramon Y Cajal T; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain., Aragón Manrique I; Genetic Counseling, Medical Oncology Department, Hospital Juan Ramón Jiménez, Huelva, Spain., Carrasco Salas P; Genetic Unit, Clinical Analysis Department, Hospital Juan Ramón Jiménez, Huelva, Spain., Puig S; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain.; Melanoma Unit, Department of Dermatology, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Aguilera P; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain.; Melanoma Unit, Department of Dermatology, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Alonso I; Clinic Institute of Gynecology, Hospital Clínic de Barcelona, Barcelona, Spain., Cebrecos I; Clinic Institute of Gynecology, Hospital Clínic de Barcelona, Barcelona, Spain., González-Bosquet E; Clinic Institute of Gynecology, Hospital Clínic de Barcelona, Barcelona, Spain., Mellado B; Uro-Oncology Unit, Medical Oncology Department, Institute of Cancer and Blood Diseases, IDIBAPS, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Ferrer-Mileo L; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain., Rodriguez-Hernandez A; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department Medicine, University of Barcelona, Barcelona, Spain., Prat A; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department Medicine, University of Barcelona, Barcelona, Spain., Muñoz M; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department Medicine, University of Barcelona, Barcelona, Spain., Gaba L; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department Medicine, University of Barcelona, Barcelona, Spain., Adamo B; Department of Medical Oncology, Institute of Cancer and Blood Diseases, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department Medicine, University of Barcelona, Barcelona, Spain., Oriola J; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Sánchez A; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain., Puig-Butillé JA; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain. japuig@clinic.cat.; Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. japuig@clinic.cat.; Molecular Biology CORE, Hospital Clínic de Barcelona, C/Villarroel, 170. Esc 5-5, 08036, Barcelona, Spain. japuig@clinic.cat.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Apr; Vol. 210 (3), pp. 507-519. Date of Electronic Publication: 2025 Feb 24.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7217
DOI:10.1007/s10549-025-07643-4